retatrutide for diabetes type 2 Lilly Prepares FDA Filing Following Additional Phase 3 Data in Diabetes, CVD Retatrutide associated with improved glycemic

The results from the Phase 2 study long-term extension over 3 years showed clinically meaningful and significant effects on slowing both cognitive and functional decline and preserved brain volume in individuals with mild cognitive impairment and two copies of the APOE4 genea group that is often unable to take currently available Alzheimers drugs due to safety concerns

A.SongY

Differential involvement of protein kinase C and protein kinase A in ghrelininduced growth hormone and gonadotrophin release from goldfish (Carassius auratus) pituitary cells

The SURMOUNT-4 trial presents another opportunity for tirzepatide to differentiate from Novos semaglutide